Net Cash Provided by (Used in) Operating Activities |
-781K |
USD |
+1.56% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-16.7K |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
3.25B |
shares |
+551% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
495M |
shares |
+145% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-798K |
USD |
-0.56% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.83M |
USD |
+5431% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
14 |
USD |
-73.6% |
Q1 2022 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
9.95M |
USD |
+374% |
Q4 2023 |
FY 2023 |
Depreciation |
466 |
USD |
+179% |
Q1 2024 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
16.7K |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
9.24M |
USD |
+356% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Authorized |
12.5M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
2.05M |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
18.2M |
USD |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
10.5M |
shares |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
9.95M |
USD |
+374% |
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
774K |
USD |
+15121% |
Q2 2024 |
Q2 2024 |
Interest Expense |
168 |
USD |
-25.7% |
Q1 2022 |
Q1 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |